Tirzepatide
Dual incretin-pathway research peptide for laboratory study of GIP and GLP-1 receptor signaling.
Long-acting GLP-1 receptor agonist analog supplied for metabolic pathway and incretin-signaling research models.
Request a lot-matched Certificate of Analysis for this research material when available. We do not host fabricated PDFs or publish invented purity statistics on product pages.
| Size | 5 mg |
|---|---|
| Form | Lyophilized powder |
| Purity / documentation | Lot-specific Certificate of Analysis provided on request when available via the Vial Vault. No instant site-wide purity claims. |
| CAS | 910463-68-2 |
| Molecular weight | 4113.6 g/mol (reference) |
| Sequence / identity | GLP-1 receptor agonist peptide analog (research material) |
| Intended use | In vitro laboratory research only (RUO) |
Semaglutide research material is intended for laboratory investigation of GLP-1 receptor pathways and metabolic signaling in experimental systems. Not for human use. Use only in qualified research settings with appropriate institutional controls.
Content is for scientific reference only and does not constitute medical advice or instructions for human use.
Move from catalog specs to literature context, documentation, and lab planning tools. Research use only.
Dual incretin-pathway research peptide for laboratory study of GIP and GLP-1 receptor signaling.
Investigational triple-agonist peptide for laboratory metabolic pathway research in model systems.